tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX

OncoCyte (OCX) Technical Analysis

403 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
OncoCyte Corp’s (OCX) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting OncoCyte Corp is a Sell.
OncoCyte Corp’s (OCX) 20-Day exponential moving average is 2.73, while OncoCyte Corp’s (OCX) share price is $2.885, making it a Buy.
OncoCyte Corp’s (OCX) 50-Day exponential moving average is 2.80, while OncoCyte Corp’s (OCX) share price is $2.885, making it a Buy.

OncoCyte (OCX) Pivot Points

May 14, 2024, 09:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.56
2.63
2.76
2.83
2.96
3.03
3.16
Fibonacci
2.63
2.71
2.75
2.83
2.91
2.95
3.03
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoCyte (OCX) Moving Averages

May 14, 2024, 09:28 AM
Period
Simple
Exponential
MA5
2.84Buy
2.84Buy
MA10
2.75Buy
2.77Buy
MA20
2.64Buy
2.73Buy
MA50
2.83Buy
2.80Buy
MA100
2.94Sell
2.94Sell
MA200
3.12Sell
3.23Sell
OncoCyte Corp’s (OCX) 10-Day exponential moving average is 2.77, while OncoCyte Corp’s (OCX) share price is $2.885, making it a Buy.
OncoCyte Corp’s (OCX) 100-Day exponential moving average is 2.94, while OncoCyte Corp’s (OCX) share price is $2.885, making it a Sell.
OncoCyte Corp’s (OCX) stock price is $2.885 and OncoCyte Corp’s (OCX) 50-day simple moving average is 2.83, creating a Buy signal.
OncoCyte Corp’s (OCX) stock price is $2.885 and OncoCyte Corp’s (OCX) 100-day simple moving average is 2.94, creating a Sell signal.
OncoCyte Corp’s (OCX) stock price is $2.885 and OncoCyte Corp’s (OCX) 200-day simple moving average is 3.12, creating a Sell signal.

OncoCyte (OCX) Technical Indicators

May 14, 2024, 09:28 AM
Name
Value
Implied Action
RSI (14)
58.98
Neutral
STOCH (9,6)
95.76
Sell
STOCHRSI (14)
96.75
Sell
MACD (12,26)
0.02
Sell
ADX (14)
21.35
Neutral
Williams %R
-3.25
Sell
CCI (14)
114.43
Sell
ATR (14)
0.16
-
Ultimate Oscillator
60.36
Neutral
ROC
17.07
Buy
OncoCyte Corp’s (OCX) Relative Strength Index (RSI) is 58.98, creating a Neutral signal.
OncoCyte Corp’s (OCX) Trend Strength Indicator (ADX) is 21.35, creating a Neutral signal.
OncoCyte Corp’s (OCX) Commodity Channel Index (CCI) is 114.43, creating a Sell signal.
OncoCyte Corp’s (OCX) Price Rate of Change (ROC) is 17.07, creating a Buy signal.

FAQ

Is OCX a Buy, Hold, or Sell?
Based on OCX’s technical indicators, OCX is a Hold.
    What is OCX’s RSI (14)?
    OCX’s RSI (14) is 58.98, which suggests OCX is a Neutral.
      What is OCX’s MACD?
      OCX’s MACD is 0.02, which suggests OCX is a Sell.
        What is OCX’s 5-day moving average?
        OCX’s 5-day moving average is 2.84, which suggests OCX is a Buy.
          What is OCX’s 20-day moving average?
          OCX 20-day moving average is 2.64, which suggests OCX is a Buy.
            What is OCX’s 50-day moving average?
            OCX’s 50-day moving average is 2.83, which suggests OCX is a Buy.
              What is OCX’s 200-day moving average?
              OCX’s 200-day moving average is 3.12, which suggests OCX is a Sell.
                What is OCX’s Williams % R (14)?
                OCX’s Williams % R (14) is -3.25, which suggests OCX is a Sell.
                  What is OCX’s CCI (14)?
                  OCX’s CCI (14) is 114.43, which suggests OCX is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis